XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue Disaggregation
 3 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

 

Note 10. Revenue Disaggregation

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The following table presents the Company’s disaggregated revenues by source:

        
   Three Months Ended June 30, 
Product  2024   2023 
Human Care  $2,876,000   $2,750,000 
Animal Care   399,000    578,000 
Total Product   3,275,000    3,328,000 
Service and Royalty   116,000    99,000 
Total  $3,391,000   $3,427,000 

 

The following table shows the Company’s revenues by geographic region:

        
   Three Months Ended June 30, 
   2024   2023 
United States  $642,000   $806,000 
Europe   1,288,000    1,070,000 
Asia   477,000    862,000 
Latin America   880,000    487,000 
Rest of the World   104,000    202,000 
Total  $3,391,000   $3,427,000